The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment

by Avital Vorontsova, Tal Kan, Ziv Raviv, Yuval Shaked
Published 2020-12-01

Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks

by Kelvin K. Tsai, Tze-Sian Chan, Yuval Shaked
Published 2019-05-01

Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.

by Liat Izhak, Gizi Wildbaum, Steffen Jung, Avi Stein, Yuval Shaked, Nathan Karin
Published 2012-01-01

Correction: Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis.

by Liat Izhak, Gizi Wildbaum, Steffen Jung, Avi Stein, Yuval Shaked, Nathan Karin
Published 2018-01-01

Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide

by Urban Emmenegger, Giulio Francia, Annabelle Chow, Yuval Shaked, Andrew Kouri, Shan Man, Robert S. Kerbel
Published 2011-01-01

Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers

by Tze-Sian Chan, Tze-Sian Chan, Tze-Sian Chan, Tze-Sian Chan, Yuval Shaked, Yuval Shaked, Kelvin K. Tsai, Kelvin K. Tsai, Kelvin K. Tsai, Kelvin K. Tsai, Kelvin K. Tsai
Published 2019-07-01

Anti-VEGF-A affects the angiogenic properties of tumor-derived microparticles.

by Michal Munster, Ella Fremder, Valeria Miller, Neta Ben-Tsedek, Shiri Davidi, Stefan J Scherer, Yuval Shaked
Published 2014-01-01

CCR5 Directs the Mobilization of CD11b+Gr1+Ly6Clow Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Development

by Elias Hawila, Hila Razon, Gizi Wildbaum, Carolin Blattner, Yair Sapir, Yuval Shaked, Viktor Umansky, Nathan Karin
Published 2017-11-01

Host response to immune checkpoint inhibitors contributes to tumor aggressiveness

by Ziv Raviv, Yuval Shaked, Michal Harel, Eyal Jacob, Irina Khononov, Ella Fremder, Nili Dahan, Boris Krastev
Published 2021-03-01

Id1 restrains p21 expression to control endothelial progenitor cell formation.

by Alessia Ciarrocchi, Vladimir Jankovic, Yuval Shaked, Daniel J Nolan, Vivek Mittal, Robert S Kerbel, Stephen D Nimer, Robert Benezra
Published 2007-01-01

Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy

by Erez Hasnis, Dror Alishekevitz, Svetlana Gingis-Veltski, Rotem Bril, Ella Fremder, Tali Voloshin, Ziv Raviv, Amir Karban, Yuval Shaked
Published 2014-06-01

The Potential Role of Immune Alteration in the Cancer–COVID19 Equation—A Prospective Longitudinal Study

by Tal Goshen-Lago, Moran Szwarcwort-Cohen, Madeleine Benguigui, Ronit Almog, Ilit Turgeman, Nelly Zaltzman, Michael Halberthal, Yuval Shaked, Irit Ben-Aharon
Published 2020-08-01

Intratumoral HLA-DR−/CD33+/CD11b+ Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

by Erez Hasnis, Erez Hasnis, Aviva Dahan, Wissam Khoury, Daniel Duek, Yael Fisher, Alex Beny, Yuval Shaked, Yehuda Chowers, Elizabeth E. Half
Published 2020-08-01

21 Plasma-based proteomic profiling as a tool for predicting response to immunotherapy in melanoma patients

by Mario Sznol, Ruth Halaban, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Eran Issler, Haim Bar, Adam Dicker, Ofer Sharon, Antonietta Bacchiocchi
Published 2020-11-01

Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy

by Dvir Shechter, Michal Harel, Abhishek Mukherjee, Leonel M. Sagredo, David Loven, Elad Prinz, Shimrit Avraham, Veronique Orian-Rousseau, Tamar Geiger, Yuval Shaked, Haguy Wolfenson
Published 2020-10-01

Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer

by Maryna Bondarenko, Marion Le Grand, Yuval Shaked, Ziv Raviv, Guillemette Chapuisat, Cécile Carrère, Marie-Pierre Montero, Mailys Rossi, Eddy Pasquier, Manon Carré, Nicolas André
Published 2021-05-01

Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases

by Chen Rachman-Tzemah, Shelly Zaffryar-Eilot, Moran Grossman, Dario Ribero, Michael Timaner, Joni M. Mäki, Johanna Myllyharju, Francesco Bertolini, Dov Hershkovitz, Irit Sagi, Peleg Hasson, Yuval Shaked
Published 2017-04-01

Correction: Two roads for oncolytic immunotherapy development

by Michael Timaner, Ziv Raviv, Shai Shen-Orr, Yuval Shaked, Tongwu Zhang, Ksenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, Rachelly Normand, Brian P. James, Roi Gazit, Ze'ev A. Ronai
Published 2021-06-01

IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells

by Michael Timaner, Ziv Raviv, Shai Shen-Orr, Yuval Shaked, Tongwu Zhang, Ksenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, Rachelly Normand, Brian P. James, Roi Gazit, Ze'ev A. Ronai
Published 2021-06-01

Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3

by Dror Alishekevitz, Svetlana Gingis-Velitski, Orit Kaidar-Person, Lilach Gutter-Kapon, Sandra D. Scherer, Ziv Raviv, Emmanuelle Merquiol, Yael Ben-Nun, Valeria Miller, Chen Rachman-Tzemah, Michael Timaner, Yelena Mumblat, Neta Ilan, David Loven, Dov Hershkovitz, Ronit Satchi-Fainaro, Galia Blum, Jonathan P. Sleeman, Israel Vlodavsky, Yuval Shaked
Published 2016-10-01